Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Aug;106(4):1011–1018. doi: 10.1111/j.1476-5381.1992.tb14449.x

[3H]-RS-15385-197, a selective and high affinity radioligand for alpha 2-adrenoceptors: implications for receptor classification.

A C MacKinnon 1, A T Kilpatrick 1, B A Kenny 1, M Spedding 1, C M Brown 1
PMCID: PMC1907641  PMID: 1327384

Abstract

1. RS-15385-197 is the most potent and selective alpha 2-adrenoceptor antagonist available. We have used [3H]-RS-15385-197 to define alpha 2-adrenoceptor subtypes. The binding of [3H]-RS-15385-197 to membranes of rat cerebral cortex, rat neonatal lung and human platelets was reversible, saturable and of high affinity. Saturation experiments indicated that [3H]-RS-15385-197 bound to a single population of sites in all 3 tissues with high affinity (0.08-0.14 nM). The density of sites labelled by [3H]-RS-15385-197 was greater in the cortex (275 fmol mg-1 protein) than in the neonate lung (174 fmol mg-1 protein) and human platelet (170 fmol mg-1 protein). The density of sites labelled with [3H]-RS-15385-197 in the cortex was significantly greater than that labelled with [3H]-yohimbine (121 fmol mg-1 protein). 2. The selective alpha 2-adrenoceptor antagonists, idazoxan, yohimbine, rauwolscine and WY 26703 displaced [3H]-RS-15385-197 binding to rat cerebral cortex in a simple manner with Hill slopes close to unity. The affinities derived for these antagonists against [3H]-RS-15385-197 were similar to the values obtained for the displacement of [3H]-yohimbine indicating the alpha 2-adrenoceptor nature of the binding site. 3. alpha 2A-Adrenoceptor selective compounds, oxymetazoline and BRL 44409, showed high affinity for [3H]-RS-15385-197 binding in the human platelet and lower affinity in the neonate lung, while the alpha 2B-selective compounds, prazosin and imiloxan, showed high affinity for [3H]-RS-15385-197 binding in the neonate lung.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
1011

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broadhurst A. M., Alexander B. S., Wood M. D. Heterogeneous 3H-rauwolscine binding sites in rat cortex: two alpha 2-adrenoceptor subtypes or an additional non-adrenergic interaction? Life Sci. 1988;43(1):83–92. doi: 10.1016/0024-3205(88)90240-8. [DOI] [PubMed] [Google Scholar]
  2. Broadhurst A. M., Wyllie M. G. A reassessment of the binding of [3H]rauwolscine to membranes from the rat cortex. Neuropharmacology. 1986 Mar;25(3):287–295. doi: 10.1016/0028-3908(86)90254-6. [DOI] [PubMed] [Google Scholar]
  3. Brown C. M., MacKinnon A. C., McGrath J. C., Spedding M., Kilpatrick A. T. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain. Br J Pharmacol. 1990 Apr;99(4):803–809. doi: 10.1111/j.1476-5381.1990.tb13010.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown C. M., MacKinnon A. C., McGrath J. C., Spedding M., Kilpatrick A. T. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide. Br J Pharmacol. 1990 Mar;99(3):481–486. doi: 10.1111/j.1476-5381.1990.tb12954.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bylund D. B. Heterogeneity of alpha-2 adrenergic receptors. Pharmacol Biochem Behav. 1985 May;22(5):835–843. doi: 10.1016/0091-3057(85)90536-2. [DOI] [PubMed] [Google Scholar]
  6. Bylund D. B., Ray-Prenger C., Murphy T. J. Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J Pharmacol Exp Ther. 1988 May;245(2):600–607. [PubMed] [Google Scholar]
  7. Bylund D. B., U'Prichard D. C. Characterization of alpha 1- and alpha 2-adrenergic receptors. Int Rev Neurobiol. 1983;24:343–431. [PubMed] [Google Scholar]
  8. Chalberg S. C., Duda T., Rhine J. A., Sharma R. K. Molecular cloning, sequencing and expression of an alpha 2-adrenergic receptor complementary DNA from rat brain. Mol Cell Biochem. 1990 Sep 21;97(2):161–172. doi: 10.1007/BF00221058. [DOI] [PubMed] [Google Scholar]
  9. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  10. Cheung Y. D., Barnett D. B., Nahorski S. R. [3H]Rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: possible heterogeneity of alpha 2-adrenoceptors. Eur J Pharmacol. 1982 Oct 15;84(1-2):79–85. doi: 10.1016/0014-2999(82)90159-5. [DOI] [PubMed] [Google Scholar]
  11. Clark R. D., Repke D. B., Kilpatrick A. T., Brown C. M., MacKinnon A. C., Clague R. U., Spedding M. (8a alpha,12a alpha,13a alpha)-5,8,8a,9,10,11,12,12a,13,13a-decahydro- 3-methoxy-12-(methylsulfonyl)-6H-isoquino[2,1-g][1,6]naphthyridi ne, a potent and highly selective alpha 2-adrenoceptor antagonist. J Med Chem. 1989 Sep;32(9):2034–2036. doi: 10.1021/jm00129a002. [DOI] [PubMed] [Google Scholar]
  12. Convents A., Convents D., De Backer J. P., De Keyser J., Vauquelin G. High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes. Biochem Pharmacol. 1989 Feb 1;38(3):455–463. doi: 10.1016/0006-2952(89)90385-7. [DOI] [PubMed] [Google Scholar]
  13. Daiguji M., Meltzer H. Y., U'Prichard D. C. Human platelet alpha 2-adrenergic receptors: labeling with 3H-yohimbine, a selective antagonist ligand. Life Sci. 1981 Jun 15;28(24):2705–2717. doi: 10.1016/0024-3205(81)90171-5. [DOI] [PubMed] [Google Scholar]
  14. Dickinson K. E., McKernan R. M., Miles C. M., Leys K. S., Sever P. S. Heterogeneity of mammalian alpha 2-adrenoceptors delineated by [3H]yohimbine binding. Eur J Pharmacol. 1986 Jan 29;120(3):285–293. doi: 10.1016/0014-2999(86)90469-3. [DOI] [PubMed] [Google Scholar]
  15. Diop L., Dausse J. P., Meyer P. Specific binding of [3H]rauwolscine to alpha 2-adrenoceptors in rat cerebral cortex: comparison between crude and synaptosomal plasma membranes. J Neurochem. 1983 Sep;41(3):710–715. doi: 10.1111/j.1471-4159.1983.tb04798.x. [DOI] [PubMed] [Google Scholar]
  16. Doxey J. C., Roach A. G., Smith C. F. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors. Br J Pharmacol. 1983 Mar;78(3):489–505. doi: 10.1111/j.1476-5381.1983.tb08809.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Glossmann H., Ferry D. R. Assay for calcium channels. Methods Enzymol. 1985;109:513–550. doi: 10.1016/0076-6879(85)09112-1. [DOI] [PubMed] [Google Scholar]
  18. Heuring R. E., Peroutka S. J. Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J Neurosci. 1987 Mar;7(3):894–903. doi: 10.1523/JNEUROSCI.07-03-00894.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kobilka B. K., Matsui H., Kobilka T. S., Yang-Feng T. L., Francke U., Caron M. G., Lefkowitz R. J., Regan J. W. Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor. Science. 1987 Oct 30;238(4827):650–656. doi: 10.1126/science.2823383. [DOI] [PubMed] [Google Scholar]
  20. Langin D., Lafontan M., Stillings M. R., Paris H. [3H]RX821002: a new tool for the identification of alpha 2A-adrenoceptors. Eur J Pharmacol. 1989 Aug 11;167(1):95–104. doi: 10.1016/0014-2999(89)90751-6. [DOI] [PubMed] [Google Scholar]
  21. Lanier S. M., Downing S., Duzic E., Homcy C. J. Isolation of rat genomic clones encoding subtypes of the alpha 2-adrenergic receptor. Identification of a unique receptor subtype. J Biol Chem. 1991 Jun 5;266(16):10470–10478. [PubMed] [Google Scholar]
  22. Latifpour J., Jones S. B., Bylund D. B. Characterization of [3H]yohimbine binding to putative alpha-2 adrenergic receptors in neonatal rat lung. J Pharmacol Exp Ther. 1982 Dec;223(3):606–611. [PubMed] [Google Scholar]
  23. Lattimer N., McAdams R. P., Rhodes K. F., Sharma S., Turner S. J., Waterfall J. F. Alpha 2-adrenoceptor antagonism and other pharmacological antagonist properties of some substituted benzoquinolizines and yohimbine in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1984 Oct;327(4):312–318. doi: 10.1007/BF00506242. [DOI] [PubMed] [Google Scholar]
  24. MacKinnon A. C., Brown C. M., Spedding M., Kilpatrick A. T. [3H]-idazoxan binds with high affinity to two sites on hamster adipocytes: an alpha 2-adrenoceptor and a non-adrenoceptor site. Br J Pharmacol. 1989 Dec;98(4):1143–1150. doi: 10.1111/j.1476-5381.1989.tb12658.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Michel A. D., Loury D. N., Whiting R. L. Assessment of imiloxan as a selective alpha 2B-adrenoceptor antagonist. Br J Pharmacol. 1990 Mar;99(3):560–564. doi: 10.1111/j.1476-5381.1990.tb12968.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Michel A. D., Loury D. N., Whiting R. L. Differences between the alpha 2-adrenoceptor in rat submaxillary gland and the alpha 2A-and alpha 2B-adrenoceptor subtypes. Br J Pharmacol. 1989 Nov;98(3):890–897. doi: 10.1111/j.1476-5381.1989.tb14618.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  28. Petrash A. C., Bylund D. B. Alpha-2 adrenergic receptor subtypes indicated by [3H]yohimbine binding in human brain. Life Sci. 1986 Jun 9;38(23):2129–2137. doi: 10.1016/0024-3205(86)90212-2. [DOI] [PubMed] [Google Scholar]
  29. Pettibone D. J., Clineschmidt B. V., Lotti V. J., Baldwin J. J., Huff J. R., Randall W. C., Vacca J., Young S. D. Pharmacological profile of a new potent and specific alpha 2-adrenoceptor antagonist, L-657,743. Naunyn Schmiedebergs Arch Pharmacol. 1987 Aug;336(2):169–175. doi: 10.1007/BF00165801. [DOI] [PubMed] [Google Scholar]
  30. Pettibone D. J., Clineschmidt B. V., Lotti V. J., Martin G. E., Huff J. R., Randall W. C., Vacca J., Baldwin J. J. L-654,284 a new potent and selective alpha 2-adrenoceptor antagonist. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jun;333(2):110–116. doi: 10.1007/BF00506512. [DOI] [PubMed] [Google Scholar]
  31. Pettibone D. J., Flagg S. D., Totaro J. A., Clineschmidt B. V., Huff J. R., Young S. D., Chen R. [3H]L-657,743 (MK-912): a new, high affinity, selective radioligand for brain alpha 2-adrenoceptors. Life Sci. 1989;44(7):459–467. doi: 10.1016/0024-3205(89)90461-x. [DOI] [PubMed] [Google Scholar]
  32. Randall W. C., Huff J. R., Vacca J. P., Guare J. P., Chen R., Rosegay A., Baldwin J. J. [3H]L-654,284 as a probe of the central alpha 2 adrenoceptor. Naunyn Schmiedebergs Arch Pharmacol. 1988 Jul;338(1):47–52. doi: 10.1007/BF00168811. [DOI] [PubMed] [Google Scholar]
  33. Rouot B., Quennedey M. C., Schwartz J. Characteristics of the [3H]-yohimbine binding on rat brain alpha2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1982 Dec;321(4):253–259. doi: 10.1007/BF00498509. [DOI] [PubMed] [Google Scholar]
  34. Starke K. Presynaptic alpha-autoreceptors. Rev Physiol Biochem Pharmacol. 1987;107:73–146. [PubMed] [Google Scholar]
  35. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol. 1977;77:1–124. doi: 10.1007/BFb0050157. [DOI] [PubMed] [Google Scholar]
  36. Stillings M. R., Chapleo C. B., Butler R. C., Davis J. A., England C. D., Myers M., Myers P. L., Tweddle N., Welbourn A. P., Doxey J. C. Alpha-adrenoreceptor reagents. 3. Synthesis of some 2-substituted 1,4-benzodioxans as selective presynaptic alpha 2-adrenoreceptor antagonists. J Med Chem. 1985 Aug;28(8):1054–1062. doi: 10.1021/jm00146a013. [DOI] [PubMed] [Google Scholar]
  37. Vizi E. S., Harsing L. G., Jr, Gaal J., Kapocsi J., Bernath S., Somogyi G. T. CH-38083, a selective, potent antagonist of alpha-2 adrenoceptors. J Pharmacol Exp Ther. 1986 Aug;238(2):701–706. [PubMed] [Google Scholar]
  38. Voigt M. M., McCune S. K., Kanterman R. Y., Felder C. C. The rat alpha 2-C4 adrenergic receptor gene encodes a novel pharmacological subtype. FEBS Lett. 1991 Jan 14;278(1):45–50. doi: 10.1016/0014-5793(91)80080-m. [DOI] [PubMed] [Google Scholar]
  39. Young P., Berge J., Chapman H., Cawthorne M. A. Novel alpha 2-adrenoceptor antagonists show selectivity for alpha 2A- and alpha 2B-adrenoceptor subtypes. Eur J Pharmacol. 1989 Sep 22;168(3):381–386. doi: 10.1016/0014-2999(89)90801-7. [DOI] [PubMed] [Google Scholar]
  40. Zeng D. W., Lynch K. R. Distribution of alpha 2-adrenergic receptor mRNAs in the rat CNS. Brain Res Mol Brain Res. 1991 Jun;10(3):219–225. doi: 10.1016/0169-328x(91)90064-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES